25
Participants
Start Date
March 31, 2013
Primary Completion Date
May 31, 2013
Study Completion Date
May 31, 2013
faldaprevir(high dose)
faldaprevir(high dose) will be taken by 1 day single use and 10 days multiple use. the subjects will be assigned to high dose treatment in random order
Faldaprevir(low dose)
faldaprevir(low dose) will be taken by 1 day single use and 10 days multiple use. the subjects will be assigned to low dose treatment in random order
1220.52.86001 Boehringer Ingelheim Investigational Site, Beijing
Lead Sponsor
Boehringer Ingelheim
INDUSTRY